{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:15:10Z","timestamp":1778832910742,"version":"3.51.4"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["343933\/Z\/26\/Z"],"award-info":[{"award-number":["343933\/Z\/26\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/X001598\/1"],"award-info":[{"award-number":["MR\/X001598\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/Y001958\/1"],"award-info":[{"award-number":["MR\/Y001958\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.coviro.2026.101512","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T01:19:42Z","timestamp":1771291182000},"page":"101512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Human genetics of susceptibility to live-attenuated viral vaccines"],"prefix":"10.1016","volume":"75","author":[{"given":"Phoebe","family":"Hazenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher\u00a0JA","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2026.101512_bib1","doi-asserted-by":"crossref","first-page":"12283","DOI":"10.1073\/pnas.1400472111","article-title":"History of vaccination","volume":"111","author":"Plotkin","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coviro.2026.101512_bib2","first-page":"1017","article-title":"Clinical surveillance after feeding oral attenuated live polio vaccine","volume":"88","author":"Macdonald","year":"1963","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.coviro.2026.101512_bib3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/bmj.2.5758.380","article-title":"Dysgammaglobulinaemia complicated by disseminated measles","volume":"2","author":"Mawhinney","year":"1971","journal-title":"Br Med J"},{"key":"10.1016\/j.coviro.2026.101512_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2009.07.005","article-title":"Rotavirus vaccine induced diarrhea in a child with severe combined immune deficiency","volume":"124","author":"Werther","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coviro.2026.101512_bib5","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1073\/pnas.1220098110","article-title":"STAT2 deficiency and susceptibility to viral illness in humans","volume":"110","author":"Hambleton","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coviro.2026.101512_bib6","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1086\/374244","article-title":"Progressive vaccinia","volume":"36","author":"Bray","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2026.101512_bib7","article-title":"Association between the side effect induced by COVID-19 vaccines and the immune regulatory gene polymorphism","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2026.101512_bib8","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/cid\/cix1022","article-title":"Multivalent rotavirus vaccine and wild-type rotavirus strain shedding in Australian infants: a birth cohort study","volume":"66","author":"Ye","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2026.101512_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.786375","article-title":"Case report: rotavirus vaccination and severe combined immunodeficiency in Japan","volume":"13","author":"Tanita","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2026.101512_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jhin.2021.12.009","article-title":"Nosocomial infection with rotavirus vaccine strain in paediatric patients with immunodeficiency","volume":"121","author":"Miura","year":"2022","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.coviro.2026.101512_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00706-22","article-title":"Type III and not type I interferons efficiently prevent the spread of rotavirus in human intestinal epithelial cells","volume":"96","author":"Doldan","year":"2022","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2026.101512_bib12","first-page":"67","article-title":"The genetic basis of severe combined immunodeficiency and its variants","volume":"5","author":"Tasher","year":"2012","journal-title":"Appl Clin Genet"},{"key":"10.1016\/j.coviro.2026.101512_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/pai.13834","article-title":"Severe vaccine-acquired rotavirus infection in an infant with primary intestinal lymphangiectasia","volume":"33","author":"Cabrerizo","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.coviro.2026.101512_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/v14030459","article-title":"T-cell responses after rotavirus infection or vaccination in children: a systematic review","volume":"14","author":"Laban","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2026.101512_bib15","unstructured":"NHS England:\u00a0In-service evaluation (ISE) of screening for severe combined immunodeficiency (SCID). UK NSC\/NHS England; 2025. Available from: \u3008https:\/\/nationalscreening.blog.gov.uk\/wp-content\/uploads\/sites\/254\/2025\/11\/NHSE-England-report-on-in-service-evaluation-of-newborn-screening-for-SCID-updated-Nov-25.pdf\u3009."},{"key":"10.1016\/j.coviro.2026.101512_sbref15","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.128019","article-title":"Safety, immunogenicity, and relative efficacy of a parenteral trivalent rotavirus subunit vaccine candidate (TV P2-VP8) in healthy Ghanaian, Malawian, and Zambian infants","volume":"70","author":"Tewari","year":"2026","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2026.101512_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines13010050","article-title":"Rotavirus vaccination protects against diabetes mellitus type 1 in children in developed countries: a systematic review and meta-analysis","volume":"13","author":"Kosmeri","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.coviro.2026.101512_bib18","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/14740338.2024.2359616","article-title":"Vaccine-associated paralytic poliomyelitis in oral polio vaccine recipients: disproportionality analysis using VAERS and systematic review","volume":"23","author":"Suares","year":"2024","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.coviro.2026.101512_bib19","article-title":"Poliovirus shedding after sequential immunization of Sabin-strain inactivated polio vaccines and oral attenuated polio vaccines","volume":"10","author":"Fu","year":"2025","journal-title":"NPJ\u00a0Vaccines"},{"key":"10.1016\/j.coviro.2026.101512_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29918","article-title":"Reversion of neurovirulent mutations, recombination and high intra-host diversity in vaccine-derived poliovirus excreted by patients with primary immune deficiency","volume":"96","author":"Ben Salem","year":"2024","journal-title":"J Med Virol"},{"key":"10.1016\/j.coviro.2026.101512_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens13121128","article-title":"Immunodeficiency-related vaccine-derived poliovirus (iVDPV) infections: a review of epidemiology and progress in detection and management","volume":"13","author":"Estivariz","year":"2024","journal-title":"Pathogens"},{"key":"10.1016\/j.coviro.2026.101512_bib22","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.vaccine.2018.02.059","article-title":"New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data","volume":"36","author":"Shaghaghi","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2026.101512_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1135834","article-title":"Case report: clearance of longstanding, immune-deficiency-associated, vaccine-derived polio virus infection following remdesivir therapy for chronic SARS-CoV-2 infection","volume":"14","author":"Bermingham","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2026.101512_sbref23","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12070759","article-title":"Immunodeficiency-related vaccine-derived poliovirus (iVDPV) Excretion in an infant with severe combined immune deficiency with spillover to a parent","volume":"12","author":"Mohanty","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.coviro.2026.101512_sbref24","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-39094-0","article-title":"Asymptomatic immunodeficiency-associated vaccine-derived poliovirus infections in two UK children","volume":"14","author":"Singanayagam","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2026.101512_bib26","article-title":"Encephalitis after live measles virus vaccine","volume":"94","author":"Pestri","year":"1966","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.coviro.2026.101512_bib27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.coi.2021.05.006","article-title":"Monogenic susceptibility to live viral vaccines","volume":"72","author":"Gothe","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coviro.2026.101512_bib28","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jaip.2016.02.015","article-title":"A novel presentation of homozygous loss-of-function STAT-1 mutation in an infant with hyperinflammation\u00a0\u2014 a case report and review of the literature","volume":"4","author":"Burns","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.coviro.2026.101512_bib29","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaci.2019.02.019","article-title":"Impaired control of multiple viral infections in a family with complete IRF9 deficiency","volume":"144","author":"Garc\u00eda-Morato","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coviro.2026.101512_bib30","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1084\/jem.20182295","article-title":"Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines","volume":"216","author":"Hernandez","year":"2019","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2026.101512_sbref30","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220028","article-title":"A loss-of-function IFNAR1 allele in Polynesia underlies severe viral diseases in homozygotes","volume":"219","author":"Bastard","year":"2022","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2026.101512_sbref31","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20212427","article-title":"Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arctic","volume":"219","author":"Duncan","year":"2022","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2026.101512_bib33","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139980","article-title":"Herpes simplex encephalitis in a patient with a distinctive form of inherited IFNAR1 deficiency","volume":"131","author":"Bastard","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2026.101512_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coviro.2026.101512_bib35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.tig.2020.08.017","article-title":"Genetic lesions of type I interferon signalling in human antiviral immunity","volume":"37","author":"Duncan","year":"2021","journal-title":"Trends Genet"},{"key":"10.1016\/j.coviro.2026.101512_bib36","article-title":"Viral live-attenuated vaccines (LAVs): past and future directions","volume":"12","author":"Tang","year":"2025","journal-title":"Adv Sci"},{"key":"10.1016\/j.coviro.2026.101512_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac4227","article-title":"Human IFNAR2 deficiency: lessons for antiviral immunity","volume":"7","author":"Duncan","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coviro.2026.101512_bib38","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1093\/brain\/awv182","article-title":"Signal transducer and activator of transcription 2 deficiency is a novel disorder of mitochondrial fission","volume":"138","author":"Shahni","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.coviro.2026.101512_bib39","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s10875-019-00642-3","article-title":"Life-threatening infections due to live-attenuated vaccines: early manifestations of inborn errors of immunity","volume":"39","author":"P\u00f6yh\u00f6nen","year":"2019","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coviro.2026.101512_bib40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jaad.2023.05.058","article-title":"Cutaneous granulomas associated with rubella virus: a clinical review","volume":"90","author":"Zhang","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.coviro.2026.101512_bib41","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20240945","article-title":"ASXL1 deficiency causes epigenetic dysfunction, combined immunodeficiency, and EBV-associated lymphoma","volume":"222","author":"Fu","year":"2025","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2026.101512_bib42","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jaci.2021.05.007","article-title":"Rubella vaccine\u2013induced granulomas are a novel phenotype with incomplete penetrance of genetic defects in cytotoxicity","volume":"149","author":"Gro\u00df","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coviro.2026.101512_bib43","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.jaci.2016.06.030","article-title":"Rubella persistence in epidermal keratinocytes and granuloma M2 macrophages in patients with primary immunodeficiencies","volume":"138","author":"Perelygina","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coviro.2026.101512_bib44","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/cup.14520","article-title":"Rubella virus-associated necrotizing neutrophilic granuloma in a patient with common variable immunodeficiency","volume":"50","author":"Pei","year":"2023","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.coviro.2026.101512_bib45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00401-016-1629-y","article-title":"Deep sequencing reveals persistence of cell-associated mumps vaccine virus in chronic encephalitis","volume":"133","author":"Morfopoulou","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.coviro.2026.101512_sbref45","doi-asserted-by":"crossref","DOI":"10.1172\/JCI168321","article-title":"Human inherited complete STAT2 deficiency underlies inflammatory viral diseases","volume":"133","author":"Bucciol","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2026.101512_bib47","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/cid\/ciaa1790","article-title":"A novel case of homozygous interferon alpha\/beta receptor alpha chain (IFNAR1) deficiency with hemophagocytic lymphohistiocytosis","volume":"74","author":"Gothe","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2026.101512_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.624415","article-title":"Life-threatening influenza, hemophagocytic lymphohistiocytosis and probable vaccine-strain varicella in a novel case of homozygous STAT2 deficiency","volume":"11","author":"Freij","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2026.101512_bib49","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1126\/science.abj7965","article-title":"Mechanisms of viral inflammation and disease in humans","volume":"374","author":"Casanova","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.coviro.2026.101512_bib50","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220491","article-title":"Null IFNAR1 and IFNAR2 alleles are surprisingly common in the Pacific and Arctic","volume":"219","author":"Meyts","year":"2022","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2026.101512_sbref50","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20241413","article-title":"A common form of dominant human IFNAR1 deficiency impairs IFN-\u03b1 and -\u03c9 but not IFN-\u03b2-dependent immunity","volume":"222","author":"Al Qureshah","year":"2025","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2026.101512_sbref51","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220258","article-title":"Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination","volume":"220","author":"Sokal","year":"2023","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2026.101512_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jtm\/taw045","article-title":"Adverse event reports following yellow fever vaccination, 2007-13","volume":"23","author":"Lindsey","year":"2016","journal-title":"J Travel Med"},{"key":"10.1016\/j.coviro.2026.101512_bib54","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202486","article-title":"Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine","volume":"218","author":"Bastard","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2026.101512_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coviro.2026.101512_bib56","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220514","article-title":"Autoantibodies against type I IFNs in patients with critical influenza pneumonia","volume":"219","author":"Zhang","year":"2022","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2026.101512_sbref56","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230661","article-title":"Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in \u223c40% of patients","volume":"220","author":"Gervais","year":"2023","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2026.101512_bib58","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1172\/JCI80477","article-title":"Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency","volume":"125","author":"Walter","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2026.101512_bib59","doi-asserted-by":"crossref","DOI":"10.1590\/s1678-9946202466050","article-title":"Fatal viscerotropic and neurotropic disease after yellow fever vaccine: a rare manifestation leading to diagnosis of severe combined immunodeficiency in an infant","volume":"66","author":"Vieira","year":"2024","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.coviro.2026.101512_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250133","article-title":"YF17D-based vaccines \u2014 standing on the shoulders of a giant","volume":"54","author":"Sanchez-Felipe","year":"2024","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.coviro.2026.101512_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030289","article-title":"Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1","volume":"3","author":"Meager","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.coviro.2026.101512_bib62","doi-asserted-by":"crossref","first-page":"e2705","DOI":"10.1093\/cid\/ciaa1274","article-title":"Primary and acquired immunodeficiencies associated with severe varicella-zoster virus infections","volume":"73","author":"Ansari","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2026.101512_bib63","doi-asserted-by":"crossref","first-page":"5","DOI":"10.14785\/lymphosign-2021-0014","article-title":"Identification of a novel RAG1 hypomorphic mutation in a child presenting with disseminated vaccine-strain varicella","volume":"8","author":"Xu","year":"2021","journal-title":"LymphoSign J"},{"key":"10.1016\/j.coviro.2026.101512_bib64","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jaci.2017.03.026","article-title":"Novel PIK3CD mutations affecting N-terminal residues of p110\u03b4 cause activated PI3K\u03b4 syndrome (APDS) in humans","volume":"140","author":"Takeda","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coviro.2026.101512_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109182","article-title":"Natural history of infants with non-SCID T cell lymphopenia identified on newborn screen","volume":"245","author":"Kubala","year":"2022","journal-title":"Clin Immunol"},{"key":"10.1016\/j.coviro.2026.101512_bib66","doi-asserted-by":"crossref","first-page":"e416","DOI":"10.1093\/infdis\/jiad512","article-title":"Varicella zoster virus downregulates expression of the nonclassical antigen presentation molecule CD1d","volume":"230","author":"Traves","year":"2023","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2026.101512_bib67","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jinf.2015.04.015","article-title":"Varicella zoster virus immunity: a primer","volume":"71","author":"Duncan","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.coviro.2026.101512_bib68","article-title":"Diagnosing inborn error of immunity following the presentation of a complicated acquired infection after MMRV vaccine administration","volume":"13","author":"AlZoebie","year":"2020","journal-title":"BMJ Case Rep CP"},{"key":"10.1016\/j.coviro.2026.101512_bib69","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1172\/JCI80477","article-title":"Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency","volume":"125","author":"Walter","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2026.101512_bib70","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/imr.13304","article-title":"Human autoantibodies neutralizing type I IFNs: from 1981 to 2023","volume":"322","author":"Bastard","year":"2024","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coviro.2026.101512_bib71","unstructured":"Australian Technical Advisory Group on Immunisation:\u00a0IFNAR1 deficiency and serious adverse events following immunisation. Australian Government Department of Health; 2022.\u00a0Available from: \u3008https:\/\/www.allergy.org.au\/images\/docs\/Attachment_A_ATAGI_Statement_IFNAR1_22_April_2022.pdf\u3009."},{"key":"10.1016\/j.coviro.2026.101512_bib72","doi-asserted-by":"crossref","first-page":"943","DOI":"10.15585\/mmwr.mm6842a2","article-title":"Novel treatment of a vaccinia virus infection from an occupational needlestick \u2014 San Diego, California, 2019","volume":"68","author":"Whitehouse","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2026.101512_bib73","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s10875-021-01023-5","article-title":"Interferon-\u03b2 therapy in a patient with Incontinentia pigmenti and autoantibodies against type I IFNs infected with SARS-CoV-2","volume":"41","author":"Bastard","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coviro.2026.101512_sbref72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1013373","article-title":"Two mutations in NS2B are responsible for attenuation of the yellow fever virus (YFV) vaccine strain 17D","volume":"21","author":"Qiu","year":"2025","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2026.101512_bib75","doi-asserted-by":"crossref","first-page":"E6310","DOI":"10.1073\/pnas.1803406115","article-title":"Species-specific disruption of STING-dependent antiviral cellular defenses by the Zika virus NS2B3 protease","volume":"115","author":"Ding","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coviro.2026.101512_bib76","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01956-15","article-title":"Vaccine and wild-type strains of yellow fever virus engage distinct entry mechanisms and differentially stimulate antiviral immune responses","volume":"7","author":"Fernandez-Garcia","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2026.101512_bib77","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1128\/JVI.00245-11","article-title":"Gene-specific contributions to mumps virus neurovirulence and neuroattenuation","volume":"85","author":"Sauder","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2026.101512_bib78","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s007050050150","article-title":"Genomic sequence of the RAff27\/3 vaccine strain of rubella virus","volume":"142","author":"Pugachev","year":"1997","journal-title":"Arch Virol"},{"key":"10.1016\/j.coviro.2026.101512_bib79","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01067-25","article-title":"Mutations of two amino acids in VP5 mediate the attenuation of human rotavirus vaccine: evidence from in vitro and in vivo studies","volume":"99","author":"Bessey","year":"2025","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2026.101512_bib80","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2482286","article-title":"The live attenuated varicella-zoster virus vaccine vOka: molecular and cellular biology of its skin attenuation","volume":"21","author":"Tommasi","year":"2025","journal-title":"Hum Vaccin Immunother"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625726000040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625726000040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:04:29Z","timestamp":1778832269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625726000040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":80,"alternative-id":["S1879625726000040"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2026.101512","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human genetics of susceptibility to live-attenuated viral vaccines","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2026.101512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101512"}}